BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 6682747)

  • 1. Changes of plasminogen activator in human uterine tissue induced by intrauterine contraceptive devices.
    Shaw ST; Macaulay LK; Sun NC; Tanaka MS; Roche PC
    Contraception; 1983 Feb; 27(2):131-40. PubMed ID: 6682747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a progesterone-releasing intrauterine contraceptive device on endometrial blood vessels: a morphometric study.
    Shaw ST; Macaulay LK; Aznar R; González-Angulo A; Roy S
    Am J Obstet Gynecol; 1981 Dec; 141(7):821-7. PubMed ID: 7315908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonal intrauterine devices.
    Rybo G; Andersson K; Odlind V
    Ann Med; 1993 Apr; 25(2):143-7. PubMed ID: 8489751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of contraceptive agents on the biochemical and protein composition of human endometrium.
    Umapathysivam K; Jones WR
    Contraception; 1980 Oct; 22(4):425-40. PubMed ID: 6160951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The response of endometrial blood vessels to intrauterine contraceptive devices: an electron microscopic study.
    Sheppard BL; Bonnar J
    Br J Obstet Gynaecol; 1980 Feb; 87(2):143-54. PubMed ID: 7362802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endometrial morphometry in users of intrauterine contraceptive devices and women with ovulatory dysfunctional uterine bleeding: a comparison with normal endometrium.
    Wang IY; Russell P; Fraser IS
    Contraception; 1995 Apr; 51(4):243-8. PubMed ID: 7796590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Management of abnormal bleeding in an intrauterine device user].
    Desmons F; Adam-steen C
    Cah Sexol Clin; 1985; 11(63):185-7. PubMed ID: 12281357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endometrial lymphomyeloid cells in abnormal uterine bleeding due to levonorgestrel (Norplant).
    Clark DA; Wang S; Rogers P; Vince G; Affandi B
    Hum Reprod; 1996 Jul; 11(7):1438-44. PubMed ID: 8671483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levonorgestrel-releasing intrauterine device-wearing women express contraceptive glycodelin A in endometrium during midcycle: another contraceptive mechanism?
    Mandelin E; Koistinen H; Koistinen R; Affandi B; Seppälä M
    Hum Reprod; 1997 Dec; 12(12):2671-5. PubMed ID: 9455833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum and endometrial copper, zinc, iron and cobalt with inert and copper-containing IUCDs.
    Fahmy K; Ghoneim M; Eisa I; el-Gazar A; Afifi A
    Contraception; 1993 May; 47(5):483-90. PubMed ID: 8513675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemostasis in menstrual endometrium in the presence of an intrauterine device.
    Christiaens GC; Sixma JJ; Haspels AA
    Br J Obstet Gynaecol; 1981 Aug; 88(8):825-37. PubMed ID: 7260004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical staining of von Willebrand factor in endometrium of women during the first year of Norplant implants use.
    Au CL; Affandi B; Rogers PA
    Contraception; 1994 Nov; 50(5):477-89. PubMed ID: 7859456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uterine response to PGE2 with IUDs: a possible mechanism of action and side effect.
    Toppozada M; Rizk M; Thabet MH; Shaala S
    Contracept Deliv Syst; 1980 Oct; 1(4):349-63. PubMed ID: 12262137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intrauterine contraceptive devices on cytokine messenger ribonucleic acid expression in the human endometrium.
    Ammälä M; Nyman T; Strengell L; Rutanen EM
    Fertil Steril; 1995 Apr; 63(4):773-8. PubMed ID: 7890061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometrial morphological changes in IUD users: a review.
    Sheppard BL
    Contraception; 1987 Jul; 36(1):1-10. PubMed ID: 3117492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of intrauterine contraceptive devices on the ultrastructure of the endometrium in relation to bleeding complications.
    Sheppard BL; Bonnar J
    Am J Obstet Gynecol; 1983 Aug; 146(7):829-39. PubMed ID: 6869454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Quantitative cytochemical study of ACP and AKP activity in the endometrial bleeding associated with copper intrauterine devices (IUDs)].
    Huang LL
    Shengzhi Yu Biyun; 1991 Aug; 11(3):22-6. PubMed ID: 12343702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editorial: IUDs and heavy periods.
    Br Med J; 1976 Feb; 1(6005):304. PubMed ID: 1247833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on IUD-induced menorrhagia and increased synthesis of prostacyclin in endometrium.
    Zheng XL; Lo LL
    J Tongji Med Univ; 1988; 8(4):232-4. PubMed ID: 3150468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative study on the clinical effects and endometrial findings of IUD].
    Chao CK
    Toho Igakkai Zasshi; 1988 Mar; 34(6):550-60. PubMed ID: 12343145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.